StonvexLoading…
StonvexStonvexStonvexCore line items from BYSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $1.35M |
Operating Income | $-8.95M | $-8.75M | $-15.08M | $-37.24M |
Net Income | $-1.01M | $-11.12M | $-21.03M | $-33.28M |
EPS (Diluted) | $-0.02 | $-0.28 | $-0.54 | $-0.85 |
Total Assets | $25.93M | $34.31M | $24.81M | $46.22M |
Total Liabilities | $49.92M | $48.60M | $48.27M | $49.23M |
Cash & Equivalents | $7.79M | $2.92M | $5.40M | $34.40M |
Free Cash Flow OCF − CapEx | $-19.82M | $-16.67M | $-16.57M | $-27.50M |
Shares Outstanding | Not available | 40.32M | 39.03M | 39.00M |